Engineering and Manufacturing for Biotechnology - Marcel Hofman & Philippe Thonart
.pdf1. Introduction...................................................................................................... |
203 |
2. Gas concentrations in batch-wise cell cultures................................................. |
204 |
2.1. Oxygen Uptake Rate (OUR)...................................................................... |
204 |
2.2. Carbon dioxide equilibrium in the gas phase............................................. |
205 |
2.3. Carbon dioxide equilibrium in the liquid phase......................................... |
206 |
3. Software sensor design..................................................................................... |
208 |
3.1. Dynamic model.......................................................................................... |
208 |
3.2. The Kalman filter algorithm...................................................................... |
209 |
4. Application of the software sensor................................................................... |
211 |
4.1. Validation of the software sensor.............................................................. |
211 |
4.2. Application to cell cultivation ................................................................... |
213 |
4.3. Robustness of the software sensor............................................................. |
214 |
5. Concluding remarks......................................................................................... |
215 |
References............................................................................................................ |
216 |
Fermentation phase detection using fuzzy clustering techniques and neural networks
for improved control................................................................................................. |
217 |
||
Takoi K. Hamrita and Shu Wang ............................................................................. |
217 |
||
1. Introduction |
...................................................................................................... |
217 |
|
2. Fermentation phase detection ........................................................................... |
218 |
||
|
2.1. Off-line ........................................phase detection using fuzzy clustering |
218 |
|
|
2.1.1. ............................................Variable selection for phase detection |
218 |
|
|
2.1.2. Fuzzy clustering for off-line phase detection of penicillin-G fed- |
|
|
|
batch fermentation.................................................................................... |
218 |
|
|
2.1.3. |
Fuzzy clustering for off - line phase detection of gluconic acid batch |
|
|
fermentation.............................................................................................. |
221 |
|
|
2.2. Neural ...................................networks for on-line fuzzy phase detection |
222 |
|
3. |
Conclusion........................................................................................................ |
|
225 |
References............................................................................................................ |
|
225 |
|
Simulation, design ...........and model based predictive control of photobioreactors |
227 |
||
J.-F. Cornet, C.G. ............................................................Dussap and J.-J. Leclercq |
227 |
||
Abstract................................................................................................................. |
|
227 |
|
1. |
Introduction...................................................................................................... |
227 |
|
2. |
Modelling .............................................................................. |
photobioreactors |
228 |
|
2.1. Radiative ...................................................................transfer formulation |
228 |
|
|
2.2. Computing ...............................................................the optical properties |
230 |
|
|
2.3. Coupling ..........................radiative transfer with rates and stoichiometry |
232 |
|
3. Results and discussions..................................................................................... |
234 |
||
|
3.1. Simulation ...............................................................................and design |
235 |
|
|
3.2. Model based .................................................................predictive control |
236 |
|
4. |
Conclusions ...........................................................................and perspectives |
236 |
|
Acknowledgement................................................................................................ |
238 |
||
References............................................................................................................ |
|
238 |
|
PART |
V Reactor ................................................................................... |
Engineering |
239 |
Bioreactors for space .......................................: biotechnology of the next century |
241 |
8
Isabelle Walther, Bart Van Der Schoot, Marc Boillat and Augusto Cogoli............ |
241 |
|
Summary.............................................................................................................. |
|
241 |
1. Introduction..................................................................................................... |
241 |
|
2. Space bioreactors: instrument......................................................................... |
242 |
|
2.1. Large space bioreactors............................................................................ |
243 |
|
2.2. Miniature space bioreactors...................................................................... |
244 |
|
2.2.1. The DCCS...................................................................................... |
244 |
|
2.1.2. The Swiss space bioreactor: SBR I................................................ |
245 |
|
3. Space bioreactor SBRI: performances in flight.............................................. |
246 |
|
3.1. Liquid handling........................................................................................ |
246 |
|
3.2. Chemical measurement and control.......................................................... |
247 |
|
3.3. System control.......................................................................................... |
249 |
|
3.4. Biological analyses................................................................................... |
249 |
|
4. Conclusions and perspectives........................................................................... |
250 |
|
Acknowledgements.............................................................................................. |
251 |
|
References............................................................................................................ |
|
251 |
PART VI Immobilisation and Permeabilisation...................................................... |
253 |
|
State of the art developments in immobilised yeast technology for brewing........... |
255 |
|
C.A. Masschelein and J. Vandenbussche ................................................................. |
255 |
|
1. Process requirements for high turnover rates in brewery fermentations .......... |
255 |
|
2. Matrix design for application in the brewing process....................................... |
257 |
|
3. Reactor design for application in the brewing process..................................... |
258 |
|
4. Reactor configuration for continuous immobilised yeast fermentation systems |
||
|
|
259 |
5. Flavour development and control in immobilised yeast systems ..................... |
261 |
|
6. Technological potential of options for immobilised yeast application in the |
|
|
brewing industry................................................................................................... |
262 |
|
6.1. Immobilised primary fermentation............................................................ |
263 |
|
6.1.1. Packed bed reactor systems ............................................................ |
263 |
|
6.1.2. |
Gas lift draft tube reactor systems .................................................. |
264 |
6.1.3. Loop reactor systems...................................................................... |
265 |
|
6.2. Fast flowing immobilised yeast systems for the production of low and |
|
|
alcohol-free beer............................................................................................... |
267 |
|
6.2.1 |
Packed bed reactors......................................................................... |
268 |
6.2.2 |
Fluidised bed reactors...................................................................... |
269 |
6.2.3 Gas lift loop reactor......................................................................... |
270 |
|
6.3. Immobilised yeast systems for continuous flavour maturation of beer..... |
271 |
|
6.3.1. DEAE cellulose carrier (Spezyme®).............................................. |
271 |
|
6.3.2. Sintered glass bead carrier (Siran ®)............................................... |
273 |
|
7. Concluding remarks......................................................................................... |
274 |
|
References ............................................................................................................ |
|
274 |
Immobilized yeast bioreactor systems for brewing – Recent achievements............. |
277 |
|
Viktor A. Nedovic, Bojana Obradovic, Ida Leskosek-Cukalovic and Gordana |
|
|
Vunjak-Novakovic................................................................................................... |
277 |
9
1. Immobilised cell systems in biotechnology...................................................... |
277 |
||
2. Applications of immobilised yeast systems in brewing.................................... |
278 |
||
2.1. Cell carriers and immobilization methods................................................. |
278 |
||
|
2.1.1. Adsorption to a pre-formed carrier................................................. |
279 |
|
|
2.1.2. |
Cell entrapment............................................................................... |
280 |
|
2.1.3. |
Self-aggregation.............................................................................. |
280 |
|
2.1.4. |
Containment of cells behind a barrier............................................ |
280 |
2.2. Bioreactor design....................................................................................... |
281 |
||
|
2.2.1. Packed bed reactor.......................................................................... |
281 |
|
|
2.2.2. |
Fluidised bed reactor....................................................................... |
282 |
|
2.2.3. |
Silicon carbide cartridge loop Reactor........................................... |
282 |
|
2.2.4. |
Internal loop gas-lift reactor......................................................... |
283 |
3. Alginate-gas-lift bioreactor system................................................................... |
283 |
||
3.1. Alginate microbeads loaded with yeast cells............................................. |
283 |
||
3.2. Internal loop gas-lift bioreactor................................................................. |
285 |
||
3.3. Beer fermentation in alginate-gas-lift bioreactor system........................... |
285 |
||
4. Conclusion........................................................................................................ |
|
289 |
|
References ............................................................................................................ |
|
289 |
|
New matrices and bioencapsulation processes......................................................... |
293 |
||
Ulrich Jahnz, Peter Wittlich, Ulf Prüsse and Klaus-Dieter Vorlop........................... |
293 |
||
Summary............................................................................................................... |
|
293 |
|
1. Introduction...................................................................................................... |
293 |
||
1.1. Techniques for the immobilisation process............................................... |
293 |
||
1.2. Short overview of suitable materials for encapsulation............................. |
294 |
||
1.3. Shapes of particles with immobilised biocatalysts .................................... |
294 |
||
2. Techniques for bead production....................................................................... |
295 |
||
2.1. Blow-off-devices..................................................................................... |
297 |
||
2.2. |
Vibration.................................................................................................... |
297 |
|
2.3. |
Atomizers................................................................................................ |
297 |
|
2.4. |
JetCutting................................................................................................ |
298 |
|
3. Materials for encapsulation............................................................................... |
301 |
||
3.1. Natural polysaccharides for ionotropic gelation........................................ |
301 |
||
3.2. Synthetic hydrogels by chemical reaction................................................. |
301 |
||
3.3. Hydrogels from polyvinyl alcohol............................................................. |
302 |
||
4. LentiKats®......................................................................................................... |
|
302 |
|
4.1. Description of properties........................................................................... |
302 |
||
4.2. Production devices for laband technical scale......................................... |
303 |
||
4.3. Examples for applications of LentiKats®................................................... |
305 |
||
5. Conclusions...................................................................................................... |
|
306 |
|
References............................................................................................................ |
|
306 |
|
PART VII Downstream Processing........................................................................... |
309 |
||
Industrial downstream processing............................................................................ |
311 |
||
MadsLaustsen.......................................................................................................... |
|
311 |
|
1. Introduction...................................................................................................... |
311 |
10
2. General aspects connected to |
downstream processing..................................... |
311 |
|||
|
2.1. Intellectual property rights |
......................................................................... |
311 |
||
|
2.2. Public research in downstream processing................................................ |
312 |
|||
|
2.3. Quality....................................................................................................... |
|
312 |
||
|
2.4. Upstream process....................................................................................... |
|
313 |
||
3. |
Pharmaceutical production............................................................................... |
|
314 |
||
|
3.1. General downstream issues........................................................................ |
314 |
|||
|
3.2. |
Recovery.................................................................................................... |
|
315 |
|
|
|
3.2.1. Primary separation.......................................................................... |
315 |
||
|
|
3.2.2. |
Intracellular products...................................................................... |
315 |
|
|
|
3.2.3. |
Concentration.................................................................................. |
|
316 |
|
|
3.2.4. |
Precipitation/crystallisation........................................................... |
316 |
|
|
3.3 Purification................................................................................................. |
|
316 |
||
|
|
3.3.1. |
Chromatographic |
principles............................................................ |
316 |
|
|
3.3.2. Matrix quality................................................................................. |
|
317 |
|
|
3.4. Research and development of particular interest for pharmaceutical |
|
|||
|
downstream |
processing..................................................................................... |
|
318 |
|
4. Enzyme production........................................................................................... |
|
318 |
|||
|
4.1. General downstream issues related to enzyme production........................ |
318 |
|||
|
4.2. Harvest....................................................................................................... |
|
320 |
||
|
4.3. Concentration............................................................................................. |
|
320 |
||
|
4.4. Purification................................................................................................ |
|
321 |
||
|
4.5. Future challenges connected to downstream processing of bulk enzymes. |
||||
|
|
|
|
|
322 |
5. Summary........................................................................................................... |
|
|
323 |
||
References............................................................................................................ |
|
|
323 |
||
Separation |
of |
lactalbumin and |
lactoglobulin by preparative chromatography |
|
|
using simulated moving beds................................................................................... |
|
325 |
|||
S.L. Lucena, P.T.V. Rosa, L.T. Furlan and C.C. Santana ........................................ |
325 |
||||
Abstract................................................................................................................. |
|
|
325 |
||
1. |
Introduction.................................................................................................... |
|
325 |
||
2. |
Basic concepts of processes of separation with simulated moving beds.......... |
327 |
|||
3. |
Mathematical formulation................................................................................ |
|
328 |
||
|
3.1. Application for a column of adsorption..................................................... |
329 |
|||
|
3.2. Application to the simulated moving bed.................................................. |
329 |
|||
4. |
Adsorption isotherms........................................................................................ |
|
330 |
||
5. |
Results and discussion...................................................................................... |
|
330 |
||
|
5.1. Individual column of adsorption................................................................ |
330 |
|||
|
5.2. Simulated moving bed............................................................................... |
|
332 |
||
6. Conclusions...................................................................................................... |
|
335 |
|||
References............................................................................................................ |
|
|
336 |
||
Appendix.............................................................................................................. |
|
|
337 |
||
High-speed pectic enzyme fractionation by immobilised metal ion affinity |
|
||||
membranes............................................................................................................... |
|
|
339 |
||
Silvia Andrea Camperi, Mariano Grasselli and Osvaldo Cascone ........................... |
339 |
11
Abstract................................................................................................................. |
|
|
339 |
|
1. |
Introduction...................................................................................................... |
|
|
339 |
2. Materials and methods...................................................................................... |
|
341 |
||
|
2.1. Enzymes and reagents ............................................................................... |
|
341 |
|
|
2.2. Histidine, lysozyme, myoglobin and haemoglobin concentration |
|
||
|
measurements................................................................................................... |
|
|
341 |
|
2.3. Pectic enzyme assay .................................................................................. |
|
341 |
|
|
2.4. Chelating hollow fibre synthesis................................................................ |
|
341 |
|
|
2.5. pure water flux determination for a single chelating hollow fibre............. |
342 |
||
|
2.6. Measurement of the amount of ida introduced.......................................... |
342 |
||
|
2.7. Adsorption isotherms measurement........................................................... |
|
343 |
|
|
2.8. Assembing a hollow-fibre membrane module........................................... |
343 |
||
|
2.9. Breakthrough curves for pe and pl adsorption........................................... |
343 |
||
|
2.10. Utilisation of the Cu(II)IDA-cartridge for pectic enzyme fractionation.. 343 |
|||
3. Results and discussion...................................................................................... |
|
344 |
||
|
3.1. Chromatographic characterisation of the derivatised membranes............. |
344 |
||
|
3.2. Properties of the hollow-fibre membrane module..................................... |
346 |
||
|
3.3. Breakthrough curves for pe and pl adsorption........................................... |
346 |
||
|
3.4. Utilisation of the ida-cartridge for pectic enzyme fractionation................ |
346 |
||
4. |
Conclusions...................................................................................................... |
|
|
348 |
Acknowledgements.............................................................................................. |
|
|
348 |
|
References............................................................................................................ |
|
|
348 |
|
PART VIII Economic finalities.................................................................................. |
|
351 |
||
Economic benefits of the application of biotechnology - Examples........................ |
353 |
|||
Marlene Etschmann, Peter Gebhart and Dieter Sell................................................. |
353 |
|||
Summary............................................................................................................... |
|
|
353 |
|
Overview.............................................................................................................. |
|
|
353 |
|
1. |
Production of 7-aminocephalosporanic |
acid ................................................... |
354 |
|
2. |
Stonewashing of jeans...................................................................................... |
|
354 |
|
3. |
Production of riboflavin ................................................................................... |
|
355 |
|
4. Biopulping........................................................................................................ |
|
|
356 |
|
5. |
Bleach cleanup.................................................................................................. |
|
|
356 |
|
5.1. Materials and |
methods............................................................................... |
|
357 |
|
5.1.1. Selection |
of the production |
plant.................................................... |
357 |
|
5.1.2. The process..................................................................................... |
|
357 |
|
|
5.1.3. Economic analysis.......................................................................... |
|
358 |
|
|
5.2. Results....................................................................................................... |
|
|
358 |
6. |
Conclusions...................................................................................................... |
|
|
360 |
References............................................................................................................ |
|
|
360 |
|
Enzyme stability and stabilisation : applications and case Studies........................... |
361 |
|||
Dr. Guido A. Drago and Dr. Tim D. Gibson............................................................ |
|
361 |
||
Summary.............................................................................................................. |
|
|
361 |
|
1. |
Introduction............................................................................................................... |
|
|
361 |
2. |
Materials and methods..................................................................................... |
|
363 |
12
3. |
Results.............................................................................................................. |
|
|
364 |
|
|
3.1. Alkaline phosphatase solution stability: enzyme source and buffer |
|
|||
|
parameters......................................................................................................... |
|
364 |
||
|
3.2. Horseradish peroxidase stability in solution.............................................. |
366 |
|||
|
3.3. Alcohol oxidase dry stability : alcohol biosensors .................................... |
367 |
|||
|
3.4. Acetylcholineesterase stability and biosensors.......................................... |
368 |
|||
|
3.5. Recombinant luciferase stability in solution.............................................. |
370 |
|||
|
3.6. Immobilised glucose oxidase : pre-stabilised complexes.......................... |
371 |
|||
|
3.7. Detection |
of protein-polyelectrolyte complexes by isoelectric focusing... |
373 |
||
4. |
Discussion and conclusions............................................................................. |
374 |
|||
Acknowledgement................................................................................................ |
375 |
||||
References............................................................................................................ |
|
|
375 |
||
Improvements of enzyme stability and specificity by genetic engineering.............. |
377 |
||||
M. Pohl and M.-R. Kula........................................................................................... |
377 |
||||
1. |
Introduction...................................................................................................... |
|
377 |
||
2. |
Results............................................................................................................. |
|
|
377 |
|
|
2.1. |
Formate |
dehydrogenase............................................................................. |
377 |
|
|
2.2. Pyruvate decarboxylase............................................................................. |
379 |
|||
3. |
Conclusion........................................................................................................ |
|
382 |
||
Acknowledgement................................................................................................ |
382 |
||||
References............................................................................................................ |
|
|
382 |
||
An approach to desiccation-tolerant bacteria in starter culture production.............. |
383 |
||||
Weekers F., Jacques P., Mergeay M. and Thonart P.............................................. |
383 |
||||
1. Introduction...................................................................................................... |
|
383 |
|||
2. |
Selection of desiccation-tolerant bacteria......................................................... |
384 |
|||
3. Targets of desiccation damages and the proposed mechanisms responsible for |
|
||||
dessication |
tolerance............................................................................................. |
385 |
|||
|
3.1. Membranes ................................................................................................ |
385 |
|||
|
|
3.1.1. Membrane desiccation-damage mechanisms.................................. |
386 |
||
|
|
3.1.2. Role of disaccharides in membrane tolerance to desiccation ......... |
387 |
||
|
3.2. |
Proteins...................................................................................................... |
388 |
||
|
|
3.2.1. The anhydrobiotic cell and a water replacement hypothesis.......... |
388 |
||
|
|
3.2.2. Vitrification of the cytoplasm as mechanism of tolerance to |
|
||
|
|
desiccation................................................................................................ |
389 |
||
|
3.3. |
Nucleic |
acids.............................................................................................. |
391 |
|
|
|
3.3.1. Mechanisms of tolerance to DNA damages during desiccation ..... |
392 |
||
|
|
3.3.2. UV irradiation as a tool for the selection of drought-tolerant bacteria |
|||
|
|
|
|
|
392 |
4. Factors influencing survival............................................................................. |
393 |
||||
|
4.1. Bacterial species........................................................................................ |
393 |
|||
|
4.2. Growth conditions..................................................................................... |
393 |
|||
|
4.3. Protective |
additives.................................................................................... |
394 |
||
|
4.4. Cell |
concentration...................................................................................... |
394 |
||
|
4.5. Drying gas, rate and extend....................................................................... |
394 |
|||
|
4.6. Rehydration .............................................................................................. |
395 |
13
4.7. Stability during storage.............................................................................. |
|
395 |
|
5. Conclusions |
...................................................................................................... |
|
395 |
Acknowledgements.............................................................................................. |
|
396 |
|
References............................................................................................................ |
|
|
396 |
Biotechnological research and the dairy industry:.................................................... |
|
399 |
|
Heike Neubauer and Beat Mollet............................................................................. |
|
399 |
|
Abstract................................................................................................................. |
|
|
399 |
1. Introduction...................................................................................................... |
|
399 |
|
1 . 1 . The history of lactic acid bacteria.............................................................. |
|
399 |
|
2. Classification of lactic acid bacteria................................................................. |
|
400 |
|
2.1. The group of lactic acid bacteria............................................................... |
|
400 |
|
2.2. Classical bacterial taxonomy combined with molecular biology .............. |
401 |
||
2.3. Isolation of new strains of lactic acid bacteria........................................... |
401 |
||
3. Lactic acid bacteria as starter cultures.............................................................. |
|
402 |
|
3.1. The role of lactic acid bacteria in the fermentation of milk....................... |
402 |
||
3.2. The new age of strain and product development....................................... |
404 |
||
4. Improved starter strains – case studies............................................................. |
|
405 |
|
4.1. Selection of naturally improved strains..................................................... |
|
405 |
|
4.1.1. Mild, shelf-stable yoghurt............................................................... |
|
405 |
|
4.1.2. |
Probiotics, bacteria with health |
beneficial properties.................... |
406 |
4.2. The genetic engineering approach............................................................. |
|
408 |
|
4.2.1. Texture producing strains............................................................... |
|
408 |
|
4.2.2. |
Novel flavour producing strains.................................................... |
|
408 |
5. Outlook and Conclusions.................................................................................. |
|
409 |
|
Acknowledgements.............................................................................................. |
|
410 |
|
References............................................................................................................ |
|
|
410 |
Immobilised cell technology in winery and fruit wine production........................... |
413 |
||
Remy Cachon and Charles Divies........................................................................... |
|
413 |
|
Summary.............................................................................................................. |
|
|
413 |
1. Introduction...................................................................................................... |
|
413 |
|
2. Immobilised cell concept................................................................................. |
|
414 |
|
3. Possible applications in winery and fruit wine production.............................. |
415 |
||
3.1. Alcoholic fermentation............................................................................. |
|
415 |
|
3.1.1. Alcoholic fermentation without |
pressure............................... |
415 |
|
3.1.2. |
Alcoholic fermentation with |
pressure : elaboration of sparkling |
|
wines......................................................................................................... |
|
|
416 |
3.2. Malolactic fermentation of wine................................................................ |
|
418 |
|
4. Conclusion........................................................................................................ |
|
|
419 |
References............................................................................................................ |
|
|
419 |
A new polysaccharide derived from plant rhizosphere : production, purification and |
|||
physico-chemical properties..................................................................................... |
|
423 |
|
Crompin J.M., Gamier T., Payot T., De Baynast R.................................................. |
|
423 |
|
Summary.............................................................................................................. |
|
|
423 |
1. Introduction...................................................................................................... |
|
423 |
|
2. Materials and methods..................................................................................... |
|
424 |
14
|
2.1. Bacterial strain........................................................................................... |
424 |
|||
|
2.2. Inoculum preparation and cultural conditions........................................... |
424 |
|||
|
2.3. Recovery and |
purification of the exopolysaccharide................................. |
424 |
||
|
2.4. Rheological analysis.................................................................................. |
424 |
|||
3. Results and discussion...................................................................................... |
425 |
||||
|
3.1. Fermentation data...................................................................................... |
425 |
|||
|
3.2. Downstream |
processing............................................................................. |
425 |
||
|
3.3. Gelling properties...................................................................................... |
426 |
|||
4. |
Conclusion........................................................................................................ |
|
427 |
||
Acknowledgements.............................................................................................. |
|
428 |
|||
References............................................................................................................ |
|
|
428 |
||
Initiation, growth and immobilisation of cell cultures of Taxus spp. for paclitaxel |
|
||||
production................................................................................................................. |
|
|
429 |
||
Chi Wai Tang, Eman Zalat and Ferda Mavituna...................................................... |
429 |
||||
Summary............................................................................................................... |
|
|
429 |
||
1. |
Introduction..................................................................................................... |
|
429 |
||
|
1.1. Pharmaceuticals from plants...................................................................... |
429 |
|||
|
1.2. |
Plant |
Biotechnology................................................................................. |
431 |
|
|
1.3. |
Antitumor compounds from Taxus spp.................................................... |
431 |
||
2. |
Materials |
and methods..................................................................................... |
432 |
||
|
2.1. Plant material and chemicals ..................................................................... |
432 |
|||
|
2.2. Culture initiation and maintenance............................................................ |
433 |
|||
|
|
2.2.1. Callus initiation.............................................................................. |
433 |
||
|
|
2.2.2. Suspension culture.......................................................................... |
433 |
||
|
2.3. |
Cell |
immobilisation .................................................................................. |
434 |
|
|
2.4. |
Bioreactors................................................................................................ |
|
435 |
|
|
2.5. |
Analytical measurements.......................................................................... |
435 |
||
|
|
2.5.1. Growth............................................................................................ |
435 |
||
|
|
2.5.2. Viability.......................................................................................... |
435 |
||
|
|
2.5.3. Sugar |
analysis................................................................................. |
436 |
|
|
|
2.5.4. Taxaneanalysis............................................................................... |
436 |
||
3. |
Results and discussion..................................................................................... |
436 |
|||
|
3.1. Callus initiation.......................................................................................... |
436 |
|||
|
|
3.1.1 Effect of media and plant growth regulators .................................. |
436 |
||
|
|
3.1.2 |
Effect of light on callus initiation................................................... |
437 |
|
|
|
3.1.3 |
Effect of plant species and explant type on callus initiation........... |
437 |
|
|
|
3.1.4 |
Effect of coconut water on callus initiation.................................... |
438 |
|
|
3.2. Callus growth and maintenance................................................................. |
438 |
|||
|
|
3.2.1 |
Effect of explant type ..................................................................... |
438 |
|
|
|
3.2.2 |
Effect of light on callus growth ...................................................... |
439 |
|
|
3.3. Suspension cultures................................................................................... |
440 |
|||
|
3.4.Immobilisation |
........................................................................................... |
442 |
||
|
3.5. Growth in bioreactors................................................................................ |
443 |
|||
|
3.6. |
Paclitaxel production................................................................................ |
443 |
||
4. |
Conclusions..................................................................................................... |
|
444 |
15
Acknowledgement................................................................................................ |
|
444 |
||
References............................................................................................................ |
|
|
445 |
|
Effective biofuel production by an intelligent bioreactor......................................... |
449 |
|||
Hideki Fukuda, Akihiko Kondo, and Hideo Noda................................................... |
|
449 |
||
Abstract................................................................................................................. |
|
|
449 |
|
1. Introduction...................................................................................................... |
|
449 |
||
2. Key technologies for biofuel production.......................................................... |
|
450 |
||
2.1 |
Intelligent bioreactor using immobilized yeast cells .................................. |
450 |
||
2.2 |
Immobilizing proteins on the surface of yeast cells.................................... |
451 |
||
3. Outline of ongoing research ............................................................................. |
|
452 |
||
3.1 |
Development of highly functional yeast cells............................................. |
452 |
||
3.2 |
Development of an intelligent bioreactor system ...................................... |
453 |
||
3.3 |
Development of an optimal control system |
i n conjunction with efficient |
|
|
monitoring........................................................................................................ |
|
|
453 |
|
4. Conclusion........................................................................................................ |
|
|
454 |
|
References............................................................................................................ |
|
|
454 |
|
PART IX Patents and Licenses.................................................................................. |
|
457 |
||
Translating European biotech into US patents do’s, |
don’ts, & costs....................... |
459 |
||
Thomas M. Saunders................................................................................................ |
|
459 |
||
Introduction.......................................................................................................... |
|
|
459 |
|
1. Five important patent differences between Europe and the US........................ |
459 |
|||
1.1. One-year us grace period from first use or sale......................................... |
459 |
|||
1.2. |
Grace period (continued): tempus fugit..................................................... |
|
459 |
|
1.3. |
Duty |
of disclosure..................................................................................... |
|
460 |
1.4. Computer algorithms now patentable....................................................... |
|
460 |
||
1.5. |
First to invent versus first to file............................................................... |
|
460 |
|
2. Basic patent game theory.................................................................................. |
|
460 |
||
3. Invention germination ...................................................................................... |
|
461 |
||
3.1. Invention disclosure forms ........................................................................ |
|
461 |
||
|
3.1.1. Short forms only............................................................................. |
|
461 |
|
|
3.1.2. Who gets the forms?....................................................................... |
|
461 |
|
3.2. |
No forms.................................................................................................... |
|
462 |
|
4. Invention selection............................................................................................ |
|
462 |
||
4.1. IP focus |
...................................................................................................... |
|
462 |
|
4.2. The learning curve..................................................................................... |
|
463 |
||
4.3.The star wars test..................................................................................... |
|
463 |
||
4.4. Is there a market?....................................................................................... |
|
463 |
||
|
4.4.1. Money............................................................................................. |
|
463 |
|
|
4.4.2. Perceived need................................................................................ |
|
463 |
|
5. Points of decision.............................................................................................. |
|
464 |
||
5.1. |
Patent |
committee....................................................................................... |
|
464 |
5.2. |
Ratings....................................................................................................... |
|
464 |
|
|
5.5.1. |
A = File immediately..................................................................... |
|
464 |
|
5.5.2. |
B = Review in six months.............................................................. |
|
464 |
16
|
5.5.3. C = Indefinite hold ....................................................................... |
465 |
|
5.2.3. Hard financial facts....................................................................... |
465 |
6. Its just business................................................................................................ |
466 |
|
6.1. What is it really worth to develop and maintain ...your patent portfolio? 466 |
||
6.2. The one true answer.................................................................................. |
466 |
|
6.3. |
Nice package............................................................................................. |
468 |
|
6.3.1. Human pharmaceuticals................................................................. |
468 |
|
6.3.2. Windage......................................................................................... |
468 |
|
6.3.3. Exclusivity..................................................................................... |
468 |
|
6.3.4. Morepatentstrategy, packages II................................................. |
469 |
7. Filing a patent application ............................................................................... |
469 |
|
7.1. Input from the inventor.............................................................................. |
469 |
|
7.2. More input from the inventor.................................................................... |
470 |
|
7.3. Compile all relevant art............................................................................. |
471 |
|
|
7.3.1. Why................................................................................................ |
471 |
|
7.3.2. Yes, everything............................................................................... |
471 |
|
7.3.3. When............................................................................................... |
472 |
|
7.3.4. Searches.......................................................................................... |
472 |
8. The prior of prior art......................................................................................... |
472 |
|
8.1. In the US................................................................................................... |
472 |
|
8.2. Non-US...................................................................................................... |
473 |
|
9. Making U.S. filings/incurring........................................................................... |
473 |
|
9.1. Application preparation............................................................................. |
473 |
|
|
9.1.1. New applications............................................................................ |
473 |
|
9.1.2. Provisional applications.................................................................. |
474 |
|
9.1.3. Later applications............................................................................ |
474 |
9.2. |
Patent prosecution...................................................................................... |
475 |
|
9.2.1. First matters.................................................................................... |
475 |
|
9.2.2. Information disclosure statement (cont.)........................................ |
475 |
|
9.2.3. First office action............................................................................ |
475 |
|
9.2.4. First response.................................................................................. |
475 |
|
9.2.3. Further office actions and responses............................................... |
477 |
9.4. Maintaining pending applications.............................................................. |
477 |
|
|
9.4.1. Re-examination............................................................................... |
477 |
|
9.4.2. Reissue............................................................................................ |
478 |
|
9.4.3. Pendency......................................................................................... |
478 |
10. |
Timing............................................................................................................ |
479 |
10.1. U.S. application filing.............................................................................. |
479 |
|
10.2. On-sale bar to patentability...................................................................... |
479 |
|
|
10.2.1. Out source disaster........................................................................ |
479 |
|
10.2.2. Concept offered for sale................................................................ |
480 |
10.3. International application filing ................................................................ |
481 |
|
|
10.3.1. Priority dates................................................................................. |
481 |
|
10.3.2. Internationally file the CIP ........................................................... |
481 |
|
10.3.3. Filing costs.................................................................................... |
481 |
17